Parametric Portfolio Associates’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,107
| Closed | -$136K | – | 3594 |
|
|
2021
Q1 | $136K | Sell |
1,107
-59
| -5% | -$7.25K | ﹤0.01% | 3940 |
|
|
2020
Q4 | $133K | Sell |
1,166
-233
| -17% | -$26.6K | ﹤0.01% | 3855 |
|
|
2020
Q3 | $167K | Buy |
1,399
+547
| +64% | +$65.3K | ﹤0.01% | 3711 |
|
|
2020
Q2 | $106K | Sell |
852
-227
| -21% | -$28.2K | ﹤0.01% | 3776 |
|
|
2020
Q1 | $208K | Buy |
1,079
+632
| +141% | +$122K | ﹤0.01% | 3538 |
|
|
2019
Q4 | $149K | Buy |
447
+32
| +8% | +$10.7K | ﹤0.01% | 3801 |
|
|
2019
Q3 | $134K | Sell |
415
-515
| -55% | -$166K | ﹤0.01% | 3783 |
|
|
2019
Q2 | $401K | Buy |
930
+395
| +74% | +$170K | ﹤0.01% | 3463 |
|
|
2019
Q1 | $303K | Buy |
535
+309
| +137% | +$175K | ﹤0.01% | 3545 |
|
|
2018
Q4 | $67K | Buy |
+226
| New | +$67K | ﹤0.01% | 3824 |
|